The 22 most recent market catalysts affecting $CLS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 15, 2026
Corporate Catalyst
Neutral
Impact 65
FBN Securities Initiates Coverage On Celestica with Outperform Rating, Announces Price Target of $375
FBN Securities initiating coverage on Celestica with an 'Outperform' rating and a $375 price target is a positive development for the company. This signals that a new institutional…
Sep 11, 2026
Corporate Catalyst
Bullish
Impact 55
Celestica Appoints Todd Ankenmann CFO, Effective Oct. 1, Succeeding Mandeep Chawla
Celestica Inc. announced a key executive transition, with Todd Ankenmann taking over as CFO from Mandeep Chawla, who will move to a newly created Group President, Global Markets ro…
Aug 24, 2026
Corporate Catalyst
Bullish
Impact 65
UBS Upgrades Celestica to Buy, Raises Price Target to $430
UBS analyst David Vogt upgraded Celestica (CLS) from Neutral to Buy and raised the price target from $410 to $430. This action signals a more optimistic outlook from a prominent fi…
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 55
Barclays Maintains Overweight on Celestica, Lowers Price Target to $406
Barclays analyst Tim Long maintained an 'Overweight' rating on Celestica, signaling continued confidence in the company's long-term prospects. However, the price target was lowered…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 85
Celestica Stock Drops After Raising $3 Billion via Equity
Celestica's announcement of a $3 billion equity offering, priced at $310 per share, is the primary driver of the stock's 14% decline. Equity offerings are inherently dilutive, mean…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 85
Celestica shares are trading lower after the company announced the pricing of its $3 billion equity offering of 9,677,419 shares at $310 per share.
The announcement of a $3 billion equity offering at $310 per share, especially when the stock is trading lower, indicates a significant dilution event for existing shareholders. Th…
Aug 6, 2026
Corporate Catalyst
Neutral
Impact 75
Reported Earlier, Celestica Prices $3B Equity Offering Of 9,677,419 Common Shares At $310 Per Share
This equity offering is a significant corporate catalyst for Celestica. The issuance of 9,677,419 common shares at $310 per share, while raising a substantial $3 billion, implies a…
Aug 5, 2026
Corporate Catalyst
Bearish
Impact 85
Celestica shares are trading lower after the company announced a $3 billion equity offering.
The announcement of a $3 billion equity offering by Celestica (CLS) is a significant corporate catalyst. Such a large offering typically leads to dilution of existing shareholder v…
Aug 5, 2026
Corporate Catalyst
Neutral
Impact 85
Celestica Announces $3B Equity Offering
Celestica's $3 billion equity offering is a major corporate catalyst, primarily impacting CLS shares due to significant dilution. While the capital infusion could be used for strat…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
JP Morgan Maintains Overweight on Celestica, Raises Price Target to $485
JP Morgan analyst Joseph Cardoso has updated their outlook on Celestica, maintaining an 'Overweight' rating and raising the price target from $445 to $485. This action signals a st…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
Wolfe Research Maintains Outperform on Celestica, Raises Price Target to $475
Wolfe Research analyst George Notter has maintained an 'Outperform' rating on Celestica (CLS) and raised the price target from $425 to $475. This action signals continued confidenc…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 55
Barclays Maintains Overweight on Celestica, Lowers Price Target to $430
Barclays analyst Tim Long maintained an 'Overweight' rating on Celestica (CLS) but lowered the price target from $441 to $430. This action reflects a continued positive sentiment t…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 85
Celestica shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance above estimates. Also, the company issued its Q3 financial guidance above estimates.
This headline is a significant positive catalyst for Celestica. The combination of beating Q2 expectations, raising long-term guidance (FY26), and providing strong near-term guidan…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 85
Why Celestica Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Celestica's strong Q2 performance, with both earnings and revenue surpassing analyst expectations, is the primary driver of its pre-market stock surge. This indicates healthy deman…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 60
12 Information Technology Stocks Moving In Monday's After-Market Session
This filing details the after-market trading activity for a selection of information technology stocks. The primary drivers for these movements appear to be recent earnings reports…
Jul 27, 2026
Corporate Catalyst
Neutral
Impact 95
Celestica Stock Extends Gains After Q2 Results Beat Estimates
Celestica Inc. (CLS) delivered a robust second quarter, exceeding analyst estimates on both the top and bottom lines. This strong performance is further bolstered by the company's …
Jul 27, 2026
Corporate Catalyst
Neutral
Impact 85
Celestica Sees Q3 Adj EPS $2.88-$3.08 vs $2.65 Est; Sees Sales $5.250B-$5.550B vs $4.980B Est
Celestica's 8-K filing discloses Q3 adjusted EPS guidance of $2.88-$3.08, notably higher than the $2.65 analyst estimate, and sales guidance of $5.250 billion-$5.550 billion, also …
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 85
Celestica Raises FY2026 Adj EPS Guidance from $10.15 to $11.30 vs $10.13 Est; Raises FY2026 Sales Guidance from $19.000B to $20.500B vs $19.166B Est
Celestica (CLS) has announced a substantial increase in its FY2026 adjusted EPS guidance from $10.15 to $11.30, significantly exceeding the $10.13 analyst estimate. Concurrently, t…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 95
Celestica Q2 Adj. EPS $2.54 Beats $2.30 Estimate, Sales $4.699B Beat $4.389B Estimate
Celestica announced Q2 adjusted EPS of $2.54, exceeding the $2.30 consensus by 10.43%, and sales of $4.699 billion, beating the $4.389 billion estimate by 7.07%. These results repr…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 85
Celestica Raises FY2026 Adj EPS Guidance from $10.15 to $11.30 vs $10.15 Est; Raises FY2026 Sales Guidance from $19.000B to $20.500B vs $19.180B Est
Celestica announced a substantial increase in its FY2026 adjusted EPS guidance from $10.15 to $11.30, and its sales outlook from $19.000 billion to $20.500 billion. Both new figure…
Jul 27, 2026
Corporate Catalyst
Neutral
Impact 85
Celestica Sees Q3 Adj EPS $2.88-$3.08 vs $2.68 Est; Sees Sales $5.250B-$5.550B vs $4.995B Est
Celestica's 8-K filing reveals Q3 adjusted EPS guidance of $2.88-$3.08, comfortably above the $2.68 analyst estimate, and sales guidance of $5.250 billion-$5.550 billion, also exce…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 95
Celestica Q2 Adj. EPS $2.54 Beats $2.27 Estimate, Sales $4.699B Beat $4.372B Estimate
Celestica's Q2 earnings report shows a substantial beat on both adjusted EPS and sales estimates, with EPS up 82.73% and sales up 62.43% year-over-year. This indicates strong growt…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.